An experience with dose-escalated conformal radiation therapy in hormone-radiotherapy for prostate cancer
Gumenetskaya, Y.V.; Mardynsky, Y.S.; Karyakin, O.B.; Gulidov, I.A.; Biryukov, V.A.
Voprosy Onkologii 61(1): 57-61
2015
ISSN/ISBN: 0507-3758 PMID: 26016147 Document Number: 680598
This study presents the short-term outcomes of conformal external beam radiation therapy given in conjunction with hormone therapy to 110 patients with prostate cancer. We performed a comparative analysis of the rate and degree of radiation reactions and complications following delivery of a total dose of 70 Gy and 72-76 Gy to the tumor. In prostate cancer, a continuous course of dose-escalated conformal radiation therapy resulted in satisfactory tolerance and acceptable levels of late complications.
Document emailed within 1 workday
Related Documents
Greco, C.; Castiglioni, S.; Fodor, A.; Mazzetta, C.; De Cobelli, O.; Orecchia, R. 2004: Androgen ablation therapy does not increase the risk of late morbidity following 3D-conformal radiotherapy of organ-confined prostate cancer: the experience of the European Institute of Oncology Tumori 90(6): 567-572Poon, I.; Pintilie, M.; Potvin, M.; McGowan, T. 2004: The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy Canadian Journal of Urology 11(1): 2125-2132
Li, J.-m.; Yu, J.-m.; Liu, S.-w.; Chen, Q.; Mu, X.-k.; Jiang, Q.-a.; Zhao, M.-h.; Zhang, J.-g. 2009: Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy Zhonghua Yi Xue Za Zhi 89(45): 3201-3206
Tkachev, S.I.; Matveev, V.B.; Trofimova, O.P.; Nazarenko, A.V.; Pylova, I.V.; Priamikova, I.I. 2010: Conformal radiotherapy for prostate cancer Voprosy Onkologii 56(2): 215-219
2015: (S018) intensity-modulated radiation therapy or conformal radiation therapy and cardiopulmonary mortality risk in the elderly with esophageal cancer Oncology 29(4 Suppl. 1)
Stromberg, J.S.; Martinez, A.A.; Horwitz, E.M.; Gustafson, G.S.; Gonzalez, J.A.; Spencer, W.F.; Brabbins, D.S.; Dmuchowski, C.F.; Hollander, J.B.; Vicini, F.A. 1997: Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment Cancer Journal from Scientific American 3(6): 346-352
Pai, H.H.; Eldridge, B.; Bishop, D.; Alexander, A.; Lesperance, M.; Blood, P.; Lim, J.; Ludgate, C. 2009: Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy? Canadian Journal of Urology 16(2): 4541-4552
Inoue, Y.; Akiyama, M.; Hashine, K.; Sumiyoshi, Y. 1993: Clinical and pathological efficacies of intra-arterial infusion chemotherapy and radiotherapy combined with hormone therapy in prostate cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(11): 1686-1688
2016: (P027) Definitive Radiation Therapy for Merkel Cell Carcinoma of the Temple: Intensity-Modulated Radiotherapy (IMRT), Matched Electron Fields (MEFs), or Bolus Electron Conformal Therapy (BolusECT, .decimal Inc.)? Oncology 30 Suppl
Kawaguchi, T.; Mayama, I.; Iwabuchi, I.; Ogasawara, M.; Tsukui, A. 2010: Chemo-endocrine therapy with low-dose cisplatin, UFT, and dexamethasone for hormone-refractory prostate cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1921-1925
Malinverni, G.; Greco, C.; Bianchi, P.; Busutti, L.; Cagna, E.; Cozzarini, C.; Del Duca, M.; Franzone, P.; Frezza, G.; Gabriele, P.; Genovesi, D.; Girelli, G.Franco.; Italia, C.; Mandoliti, G.; Mauro, F.; Nava, S.; Pratissoli, S.; Saracino, M.Bianca.; Squillace, L.; Signor, M.; Tagliagambe, A.; Vavassori, V.; Villa, S.; Zini, G.; Valdagni, R. 2005: Italian survey in postoperative radiation therapy for prostate carcinoma by the AIRO National Working Group on Prostate Radiotherapy: definitive results Tumori 91(2): 156-162
Wang, Y-jie.; Wang, Lü-hua.; Lü, J-ma.; Zhao, L-jun.; Xiao, Z-fen.; Zhang, H-xing.; Feng, Q-fu.; Zhang, Z.; Yin, W-bo. 2006: Three-dimensional conformal radiotherapy for locoregionally recurrent non-small cell lung cancer after initial radiotherapy Zhonghua Zhong Liu Za Zhi 28(3): 227-229
Gao, Q-Neng. 2019: Stereotactic body radiation therapy versus conventional intensity-modulated radiation therapy for the treatment of prostate cancer Zhonghua Nan Ke Xue 25(5): 424-429
Verellen, D.; Linthout, N.; Storme, G. 1998: Target localization and treatment verification for intensity modulated conformal radiation therapy of the head and neck region. the AZ-VUB experience. Akademisch Ziekenhuis-Vrije Universiteit Brussel Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 174(Suppl 2): 19-27
Zelefsky, M.J.; Leibel, S.A.; Kutcher, G.J.; Kelson, S.; Ling, C.C.; Fuks, Z. 1995: The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma Cancer Journal from Scientific American 1(2): 142-150
Ngo, L.S.M.; Yeo, A.; Wong, A.S.C.; Tay, M.Hiang. 2007: Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore Annals of the Academy of Medicine Singapore 36(10): 811-814
Higashi, Y.; Hyochi, N.; Tari, K. 1998: Intraoperative radiotherapy combined with external beam radiation for prostate cancer without metastasis Nihon Rinsho. Japanese Journal of Clinical Medicine 56(8): 2177-2180
Schäfer, U.; Micke, O.; Hampel, G.; Brandt, B.; Bovenschulte, A.; Semjonow, A.; Willich, N. 1997: The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer Anticancer Research 17(4b): 2983-2986
Alieva, S.B.; Tkachev, S.I.; Kaledin, R.R.; Galdiyants, R.A.; Zaderenko, I.A.; Rotobelskaya, L.E. 2015: Conformal radiotherapy in nasopharyngeal cancer patients Voprosy Onkologii 61(4): 629-633
Soumarová, R.; Homola, L.; Stursa, M.; Perková, H. 2006: Acute adverse effects of high dose brachytherapy in combination with external radiotherapy in localized prostate cancer Casopis Lekaru Ceskych 145(1): 43-49